Key Team Members & Collaborators
Co-founders
Dr Sam van Bohemen, Co-founder, CEO, CTO
Dr David Cardoso, Co-founder, CBO
Strategic Advisors
Dr Philip Boughton, Biomedical Engineering
Dr David Lester, Commercialisation
Chris Baxter, Intellectual Property & Commercialisation
Commercialisation & Healthcare Readiness
Paul Cohen, Clinical & Regulatory Affairs Expert
Dr Eugene Salole, Market Access & HTA Expert
Hayley Saddington, Entrepreneurship & Commercialisation
Clinical Support
Professor Craig Anderson, Neurologist & Director of Global Brain Health at The George Institute for Global Health. President-elect of the World Stroke Organisation. h-index: 123
Associate Professor Candice Delcourt, Senior Research Fellow & Head of the Neurology Program at The George Institute for Global Health. h-index: 36
Strategic Partnership
We have formed an exciting strategic partnership with The George Institute for Global Health, a leading, not-for-profit medical research institute focused on solving the world's biggest health challenges, including stroke. We are thrilled to work together as we seek to revolutionise stroke patient care and improve outcomes, especially in underserved communities.
Cross-Disciplinary Innovation
A Wearable To Meet An Urgent Need
Stroke is a critical medical condition that is anticipated to increase in prevalence with aging populations. COVID-19 has been linked to severe ischemic strokes. Technology that can provide objective real-time insights to assist with timely interventions are being sought after to limit brain injury and death.
The proprietary nuroflux™ wearable system will non-invasively monitor brain activity and blood flow alongside vital activity to assist specialists. The current gold-standard for objective brain blood flow in stroke patients is CT perfusion imaging. Repeated CT perfusion imaging is limited due to the ionizing radiation exposure risk for patients. Furthermore, CT imaging does not provide continuous monitoring. In the time periods between CT scans (including during treatment), there is no way to quantitatively monitor brain activity and blood flow.
nuroflux™ is being developed to provide continuous, real-time monitoring of stroke patients to detect signs of new stroke events and to monitor stroke treatment.
There is also scope for the nuroflux™ device to be used in pre-hospital settings to help diagnose and monitor stroke patients.
The recurrence of stroke is a stark possibility for stroke patients in the short and long term. Therefore, the nuroflux™ device is being designed to be self-administered by high-risk patients for remote monitoring outside the clinic.
Collaborating Institutions
